481 related articles for article (PubMed ID: 30361258)
1. CRISPR-Cas9 human gene replacement and phenomic characterization in
McDiarmid TA; Au V; Loewen AD; Liang J; Mizumoto K; Moerman DG; Rankin CH
Dis Model Mech; 2018 Nov; 11(12):. PubMed ID: 30361258
[TBL] [Abstract][Full Text] [Related]
2. CRISPR/Cas9 Methodology for the Generation of Knockout Deletions in
Au V; Li-Leger E; Raymant G; Flibotte S; Chen G; Martin K; Fernando L; Doell C; Rosell FI; Wang S; Edgley ML; Rougvie AE; Hutter H; Moerman DG
G3 (Bethesda); 2019 Jan; 9(1):135-144. PubMed ID: 30420468
[TBL] [Abstract][Full Text] [Related]
3. CRISPR/Cas9 Editing of the C. elegans rbm-3.2 Gene using the dpy-10 Co-CRISPR Screening Marker and Assembled Ribonucleoprotein Complexes.
Smith A; Bergwell M; Smith E; Mathew D; Iyer J
J Vis Exp; 2020 Dec; (166):. PubMed ID: 33369608
[TBL] [Abstract][Full Text] [Related]
4. Reliable CRISPR/Cas9 Genome Engineering in
El Mouridi S; Lecroisey C; Tardy P; Mercier M; Leclercq-Blondel A; Zariohi N; Boulin T
G3 (Bethesda); 2017 May; 7(5):1429-1437. PubMed ID: 28280211
[TBL] [Abstract][Full Text] [Related]
5. An Efficient Genome Editing Strategy To Generate Putative Null Mutants in
Wang H; Park H; Liu J; Sternberg PW
G3 (Bethesda); 2018 Nov; 8(11):3607-3616. PubMed ID: 30224336
[TBL] [Abstract][Full Text] [Related]
6. Cas9 Variants Expand the Target Repertoire in Caenorhabditis elegans.
Bell RT; Fu BX; Fire AZ
Genetics; 2016 Feb; 202(2):381-8. PubMed ID: 26680661
[TBL] [Abstract][Full Text] [Related]
7. Highly Efficient, Rapid and Co-CRISPR-Independent Genome Editing in
Prior H; Jawad AK; MacConnachie L; Beg AA
G3 (Bethesda); 2017 Nov; 7(11):3693-3698. PubMed ID: 28893845
[TBL] [Abstract][Full Text] [Related]
8. The application of somatic CRISPR-Cas9 to conditional genome editing in Caenorhabditis elegans.
Li W; Ou G
Genesis; 2016 Apr; 54(4):170-81. PubMed ID: 26934570
[TBL] [Abstract][Full Text] [Related]
9. Interpreting ciliopathy-associated missense variants of uncertain significance (VUS) in Caenorhabditis elegans.
Lange KI; Best S; Tsiropoulou S; Berry I; Johnson CA; Blacque OE
Hum Mol Genet; 2022 May; 31(10):1574-1587. PubMed ID: 34964473
[TBL] [Abstract][Full Text] [Related]
10. Targeted heritable mutation and gene conversion by Cas9-CRISPR in Caenorhabditis elegans.
Katic I; Großhans H
Genetics; 2013 Nov; 195(3):1173-6. PubMed ID: 23979578
[TBL] [Abstract][Full Text] [Related]
11. Systematic phenomics analysis of autism-associated genes reveals parallel networks underlying reversible impairments in habituation.
McDiarmid TA; Belmadani M; Liang J; Meili F; Mathews EA; Mullen GP; Hendi A; Wong WR; Rand JB; Mizumoto K; Haas K; Pavlidis P; Rankin CH
Proc Natl Acad Sci U S A; 2020 Jan; 117(1):656-667. PubMed ID: 31754030
[TBL] [Abstract][Full Text] [Related]
12. [CRISPR-Cas9 mediated genome editing in Caenorhabditis elegans].
Meng X; Zhou H; Xu S
Sheng Wu Gong Cheng Xue Bao; 2017 Oct; 33(10):1693-1699. PubMed ID: 29082717
[TBL] [Abstract][Full Text] [Related]
13. Single-Copy Knock-In Loci for Defined Gene Expression in
Silva-García CG; Lanjuin A; Heintz C; Dutta S; Clark NM; Mair WB
G3 (Bethesda); 2019 Jul; 9(7):2195-2198. PubMed ID: 31064766
[TBL] [Abstract][Full Text] [Related]
14. Peel-1 negative selection promotes screening-free CRISPR-Cas9 genome editing in Caenorhabditis elegans.
McDiarmid TA; Au V; Moerman DG; Rankin CH
PLoS One; 2020; 15(9):e0238950. PubMed ID: 32960926
[TBL] [Abstract][Full Text] [Related]
15. Determining the Pathogenicity of a Genomic Variant of Uncertain Significance Using CRISPR/Cas9 and Human-Induced Pluripotent Stem Cells.
Ma N; Zhang JZ; Itzhaki I; Zhang SL; Chen H; Haddad F; Kitani T; Wilson KD; Tian L; Shrestha R; Wu H; Lam CK; Sayed N; Wu JC
Circulation; 2018 Dec; 138(23):2666-2681. PubMed ID: 29914921
[TBL] [Abstract][Full Text] [Related]
16. The application of CRISPR-Cas9 genome editing in Caenorhabditis elegans.
Xu S
J Genet Genomics; 2015 Aug; 42(8):413-21. PubMed ID: 26336798
[TBL] [Abstract][Full Text] [Related]
17. CRISPR/Cas9-targeted mutagenesis in Caenorhabditis elegans.
Waaijers S; Portegijs V; Kerver J; Lemmens BB; Tijsterman M; van den Heuvel S; Boxem M
Genetics; 2013 Nov; 195(3):1187-91. PubMed ID: 23979586
[TBL] [Abstract][Full Text] [Related]
18. Microinjection for precision genome editing in
Ghanta KS; Ishidate T; Mello CC
STAR Protoc; 2021 Sep; 2(3):100748. PubMed ID: 34505086
[TBL] [Abstract][Full Text] [Related]
19. Caenorhabditis elegans DAF-2 as a Model for Human Insulin Receptoropathies.
Bulger DA; Fukushige T; Yun S; Semple RK; Hanover JA; Krause MW
G3 (Bethesda); 2017 Jan; 7(1):257-268. PubMed ID: 27856697
[TBL] [Abstract][Full Text] [Related]
20. Heritable gene knockout in Caenorhabditis elegans by direct injection of Cas9-sgRNA ribonucleoproteins.
Cho SW; Lee J; Carroll D; Kim JS; Lee J
Genetics; 2013 Nov; 195(3):1177-80. PubMed ID: 23979576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
